Tickers

DBI — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-22 08:12:21.548338 UTC · finished 2026-09-22 08:21:11.379440 UTC

1. Composite Trajectory Verdict

For a retailer with high fixed occupancy and inventory costs, earnings profitability and operating cash flow generation are the primary indicators of financial performance, while balance sheet deleveraging supports liquidity resilience; all three statements carry material weight.

Composite Trajectory: Mixed

Annual revenue declined 3.9% with comparable sales down 4.3%, yet gross margin expanded 90 bps and operating profit rose 36.7%, narrowing the net loss (10-K 2026-01-31, Consolidated Statements of Operations). Quarterly Q2 2026 sales dipped 1.2% but operating profit more than doubled to $54.7M (aided by $35.5M one-time tariff recoveries) and net income turned positive (10-Q 2026-08-01, Condensed Statements of Operations). Operating cash flow improved 33.7% annually and surged year-to-date (from $1.1M to $48.2M), though Q2 benefited from $20.7M net tariff recovery cash (10-K 2026-01-31, Consolidated Statements of Cash Flows; 10-Q 2026-08-01, MD&A). Total debt fell 11.6% annually and 2.8% quarter-to-date while equity rose (10-K 2026-01-31, Note 12; 10-Q 2026-08-01, Condensed Balance Sheets). The trajectory is mixed: top-line trend is negative to flat, while profitability, cash flow, and leverage metrics are improving.

2. Red Flags

  • One-time tariff recoveries of $35.5M in Q2 2026 inflated gross margin by 490 bps (of 640 bps total improvement) and operating margin by 400 bps; related financing transaction added $16.1M interest expense (10-Q 2026-08-01, MD&A and Condensed Statements of Operations).
  • Effective tax rate of 311.5% in FY2025 due to low pre-tax income and non-deductible compensation (10-K 2026-01-31, Note 14 Income Taxes).
  • Retail segment comparable sales declined in FY2025 (-3.9%), Q2 2026 (-2.6%), and YTD 2026 (-1.9%) (10-K 2026-01-31, MD&A; 10-Q 2026-08-01, MD&A).
  • Brand Portfolio direct-to-consumer comparable sales volatile: -21.9% FY2025, +7.1% Q2 2026 (10-K 2026-01-31, MD&A; 10-Q 2026-08-01, MD&A).
  • Operating expenses as % of sales increased in Retail segment annually (+130 bps) and in Q2 2026 (+210 bps) due to deleverage (10-K 2026-01-31, MD&A; 10-Q 2026-08-01, MD&A).
  • Term Loan effective interest rate 12.1% as of Jan 31, 2026 (10-K 2026-01-31, Note 12 Debt).
  • Valuation allowance on deferred tax assets increased to $13.8M from $12.5M (10-K 2026-01-31, Note 14 Income Taxes).
  • Redeemable noncontrolling interest (Topo) increased to $5.3M from $3.3M (10-K 2026-01-31, Note 1).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Annual net sales fell 3.9% to $2.89B with total comparable sales down 4.3%, but gross margin rose 90 bps to 43.6% and operating profit increased 36.7% to $47.8M, narrowing the net loss attributable to DBI to $8.4M from $10.5M (10-K 2026-01-31, Consolidated Statements of Operations). Quarterly Q2 2026 net sales dipped 1.2% to $730.6M, yet gross margin surged 640 bps to 50.0% (including $35.5M tariff recoveries) and operating profit more than doubled to $54.7M, driving net income attributable to DBI of $17.6M vs $10.5M a year earlier (10-Q 2026-08-01, Condensed Statements of Operations). Year-to-date 2026 sales were flat at $1.43B while operating profit jumped to $73.6M from $18.2M and net income swung to $18.7M from a $7.3M loss (10-Q 2026-08-01, Condensed Statements of Operations). The improvement in profitability is partly driven by a one-time $35.5M tariff recovery in Q2, while the top line remains under pressure with declining comparable sales in the Retail segment across all periods.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Overall Assessment: Annual net cash provided by operating activities rose 33.7% to $109.9M from $82.2M, driven by improved working capital management despite a $40M tax refund in the prior year (10-K 2026-01-31, Consolidated Statements of Cash Flows). Year-to-date 2026 operating cash flow increased to $48.2M from $1.1M, benefiting from $36.8M in tariff recoveries received less $16.1M interest remitted to an investor (net $20.7M favorable impact) and improved gross profit performance (10-Q 2026-08-01, Condensed Statements of Cash Flows and MD&A). Investing cash outflows decreased annually (from $62.7M to $33.5M) due to lower capex and no acquisitions, but increased year-to-date (from $18.7M to $22.3M) on higher planned store investments (10-K 2026-01-31, Consolidated Statements of Cash Flows; 10-Q 2026-08-01, Condensed Statements of Cash Flows). Financing activities used $72.5M annually (primarily debt repayment and dividends) versus $23.9M year-to-date (net ABL Revolver payments and debt issuance costs) (10-K 2026-01-31, Consolidated Statements of Cash Flows; 10-Q 2026-08-01, Condensed Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Overall Assessment: Total debt declined 11.6% annually to $438.7M from $496.5M and fell a further 2.8% to $423.1M by Aug 1, 2026, reflecting consistent repayment of the ABL Revolver and Term Loan (10-K 2026-01-31, Note 12 Debt; 10-Q 2026-08-01, Condensed Balance Sheets and Note 9 Debt). Shareholders' equity grew 1.4% annually to $282.5M and 6.6% quarter-to-date to $301.1M, supported by net income and stock-based compensation activity (10-K 2026-01-31, Consolidated Balance Sheets; 10-Q 2026-08-01, Condensed Balance Sheets). Inventories decreased 6.0% annually to $563.5M but rose 5.5% quarter-to-date to $594.7M, consistent with seasonal build (10-K 2026-01-31, Consolidated Balance Sheets; 10-Q 2026-08-01, Condensed Balance Sheets). Cash increased to $51.6M from $44.8M a year earlier. The current ratio was 1.20 at Jan 31, 2026 vs 1.24 at Feb 1, 2025 (10-K 2026-01-31, Consolidated Balance Sheets). ABL Revolver availability stood at $146.2M as of Aug 1, 2026 (10-Q 2026-08-01, MD&A).

6. Data Gaps

  • Standalone Q1 2026 quarterly results (10-Q 2026-05-02 not fully provided).
  • Q3 2025 and Q4 2025 quarterly results (10-Q 2025-11-01 and 10-K 2026-01-31 cover FY2025 but not individual quarters beyond Q2 2025).
  • Full quarterly trend beyond two comparable quarters (Q2 and YTD).
  • Segment-level balance sheet data (not reported per filing).
  • Free cash flow metric (capex provided but not explicitly netted against operating cash flow in filings).
  • Detailed breakdown of "Other non-current liabilities" increase from $17.7M to $46.6M annually (10-K 2026-01-31, Consolidated Balance Sheets).
  • Impact of new tariffs under Section 301 and Section 338 effective July 2026 (mentioned in 10-Q 2026-08-01 but not quantified).
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status